Companies: 10,795·Total market cap: $144.5T
Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc.

VTYXNASDAQHealthcare
$14.00
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio
52W High$25
52W Low$0.783
Overview

Ventyx Biosciences, Inc. (VTYX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · VTYX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.50vtyx eps ttm · vtyx earnings per shareEarnings history
PE Ratio (TTM)vtyx pe ratio ttm · vtyx price to earningsPE Ratio deep dive
Revenue (TTM)0.00vtyx revenue ttm · vtyx annual revenueFull revenue history
Dividend YieldNo Dividenddoes vtyx pay dividends · vtyx dividend yieldDividend history
Shares Outstanding68.5Mvtyx shares outstanding · vtyx floatShares outstanding history
Next EarningsTBAvtyx earnings date · vtyx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
ventyx biosciences, inc. revenue · vtyx revenue 2024
FY 2024Net Income-$135.1M▲ +29.97% YoY
202220232024
ventyx biosciences, inc. net income · vtyx profit 2024
FY 2024EPS$-1.97▲ +40.30% YoY
202220232024
vtyx eps · ventyx biosciences, inc. earnings per share 2024
TTM:Revenue: $0.00Net Income: -$106.6MEPS: $-1.50View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold13 analystsis vtyx a buy · vtyx analyst rating
Strong Buy
0
Buy
4
Hold
9
Sell
0
Strong Sell
0
12-Month Price Target
$14.00Low
$14.00Current
$14.00Avg Target0.00% upside
$14.00High
vtyx price target · vtyx 12 month forecast

Total: 13 · Buy rate: 30.8%

The VTYX analyst consensus is Hold, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $14.00, representing +0.00% upside from the current price of $14.00.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+79.03%
YTD+66.67%
1Y+1574.44%
5Y-33.40%

About Ventyx Biosciences, Inc.

CEOSheila K. Gujrathi
IPO DateOct 21, 2021
Employees81
CountryUS

Ventyx Biosciences, Inc. a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidat…

what is ventyx biosciences, inc. · vtyx stock overview · ventyx biosciences, inc. company profile · who is ventyx biosciences, inc. ceo · vtyx NASDAQ · ventyx biosciences, inc. headquarters · ventyx biosciences, inc. business segments

About Stock Overview & Key Data

Ventyx Biosciences, Inc. (VTYX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 21, 2021. As of the latest trading session, VTYX stock price is $14.00, with a market capitalization of $1.0B. The stock has returned +1574.44% over the past 12 months and +66.67% year-to-date.

According to 13 Wall Street analysts, the consensus rating for Ventyx Biosciences, Inc. stock is Hold, with an average 12-month price target of $14.00. In fiscal year 2024, Ventyx Biosciences, Inc. reported revenue of — and net income of -$135.1M. For detailed data — including Ventyx Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Ventyx Biosciences, Inc. (VTYX) stock price is $14.00. The stock is traded on NASDAQ under the ticker symbol VTYX. The 52-week range is $0.78 – $25.00.

VTYX stock priceVTYX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice